Clinical Trial Update: Pathway M-1: Sphenopalatine Ganglion Stimulation for the AcuteTreatment of High Disability Migraine Headache [NA]

View source ↗

Summary

Completed clinical trial update for Pathway M-1 evaluating sphenopalatine ganglion stimulation for the acute treatment of high-disability migraine. The trial st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine

Snippet

Sponsor: Autonomic Technologies, Inc. | Conditions: High Frequency, High Disability Migraine | NA | Status: COMPLETED